Orchid Pharma has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (USFDA) for Aripiprazole tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg on May 24, 2017.